Finland Targets High-Value Ingredient Export: Dairy, Oats, and Novel Proteins Drive Innovation

Finland's ingredient sector is strategically positioning itself as a hub for high-value, functional raw materials, foregoing volume-based competition. Key players like Valio (dairy), Raisio (oats), and Solar Foods (microbial protein) exemplify this approach, leveraging the nation's scientific expertise, collaborative ecosystem, and specific agricultural advantages. The focus is on developing ingredients that offer specialised functionality, traceability, and enhanced sustainability credentials for global export markets.

Valio is expanding its dairy innovation beyond conventional protein fortification, targeting recovery, metabolic health, and hybrid formulations. Its recovery drink concept, utilising milk protein and carbohydrates from hydrolysed lactose, aims to replenish energy stores effectively while offering lactose-free benefits. This R&D demonstrates a shift towards developing 'outcome-focused' ingredients for wellness consumers, addressing specific needs like healthy aging and digestive well-being. Furthermore, Valio anticipates increased demand for dairy-plant protein hybrids, where dairy components improve taste and texture, particularly at high protein inclusion levels.

Raisio is similarly elevating oats through advanced processing. Its FiprOat programme employs fine milling and air classification to produce bran concentrates with superior fibre, beta-glucan, and protein content, without chemical extraction. This aims to move the fibre discussion beyond basic intake, focusing on specific physiological benefits like satiety and gut health. Raisio's gluten-free oat supply chain highlights stringent quality control, with oats classified at intake and quarantined until purity standards are met, offering reliable, high-specification raw materials for manufacturers.

Solar Foods represents Finland's most disruptive innovation, cultivating Solein, a microbial protein produced using CO2 as a carbon source and hydrogen for energy, independent of conventional agriculture. Factory 01's design capacity is approximately 160 metric tons/year, with a target to reach 230 metric tons/year during 2026. The company estimates commercial viability requires an annual capacity of around 6,000 metric tons, with Factory 02 projected to reach 6,400 metric tons/year after its initial two phases. Solein is initially targeting health and performance nutrition due to higher price points, but also offers unique functional properties in everyday foods, such as creaminess in non-dairy ice cream and improved moldability in pasta, despite formulation specificities.

What this means for United Kingdom

UK brand owners will see new opportunities for premium ingredient sourcing, particularly in functional dairy, high-spec oat fractions, and novel proteins. Valio's lactose-free recovery solutions and Raisio's FiprOat offer pathways to differentiate products in the competitive sports nutrition and digestive health categories. Manufacturers should assess long-term supply agreements for Solein as Solar Foods scales, which could unlock novel texture and formulation capabilities for plant-based ranges, potentially offsetting rising ingredient costs. Regulatory vigilance is critical for novel proteins like Solein; UK compliance must be confirmed for commercial use, impacting market entry timelines. Innovation in these areas could provide a competitive edge in the UK's discerning supplement market.

For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.